Jasper Therapeutics Stock Analysis

Jasper Stock Analysis Notes

About 61.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 61.8. Jasper Therapeutics had not issued any dividends in recent years. The entity had 1:10 split on the 4th of January 2024. Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. Jasper Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 35 people. To learn more about Jasper Therapeutics call Ronald Martell at 650 549 1400 or check out https://www.jaspertherapeutics.com/.

Jasper Therapeutics Investment Alerts

Jasper Therapeutics Upcoming and Recent Events

Jasper Largest EPS Surprises

View All Earnings Estimates

Jasper Stock Institutional Investors

Note, although Jasper Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Jasper Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 333.54 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jasper Therapeutics's market, we take the total number of its shares issued and multiply it by Jasper Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Jasper Profitablity

Management Efficiency

Jasper Therapeutics has return on total asset (ROA) of (0.6009) % which means that it has lost $0.6009 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1267) %, meaning that it created substantial loss on money invested by shareholders. Jasper Therapeutics' management efficiency ratios could be used to measure how well Jasper Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/24/2024, Return On Tangible Assets is likely to drop to -0.71. In addition to that, Return On Capital Employed is likely to drop to -0.89. At this time, Jasper Therapeutics' Net Tangible Assets are relatively stable compared to the past year. As of 04/24/2024, Other Current Assets is likely to grow to about 1.8 M, while Non Current Assets Total are likely to drop slightly above 6.1 M.

Technical Drivers

As of the 24th of April, Jasper Therapeutics retains the Downside Deviation of 4.41, risk adjusted performance of 0.1528, and Market Risk Adjusted Performance of 0.4495. Jasper Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Jasper Therapeutics, which can be compared to its competitors. Please check out Jasper Therapeutics variance and potential upside to decide if Jasper Therapeutics is priced fairly, providing market reflects its last-minute price of 22.03 per share. Given that Jasper Therapeutics has jensen alpha of 0.9489, we strongly advise you to confirm Jasper Therapeutics's regular market performance to make sure the company can sustain itself at a future point.

Jasper Therapeutics Price Movement Analysis

Jasper Therapeutics Insider Trading Activities

Jasper Therapeutics Predictive Daily Indicators

Jasper Therapeutics Corporate Filings

Jasper Therapeutics Forecast Models

Jasper Therapeutics' time-series forecasting models are one of many Jasper Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jasper Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Jasper Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Jasper shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Jasper Therapeutics. By using and applying Jasper Stock analysis, traders can create a robust methodology for identifying Jasper entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Jasper analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Jasper analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Jasper Therapeutics stock analysis indicators help investors evaluate how Jasper Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Jasper Therapeutics shares will generate the highest return on investment. By understating and applying Jasper Therapeutics stock analysis, traders can identify Jasper Therapeutics position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.

Is Jasper Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jasper Therapeutics. If investors know Jasper will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jasper Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Jasper Therapeutics is measured differently than its book value, which is the value of Jasper that is recorded on the company's balance sheet. Investors also form their own opinion of Jasper Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Jasper Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jasper Therapeutics' market value can be influenced by many factors that don't directly affect Jasper Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Jasper Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jasper Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jasper Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.